Kapitall Blog (blog)Jason Kolbert, managing director for biotechnology research at Maxim Group, leverages his deep understanding of the stem cell space to uncover viable therapies that double as excellent business models. In this interview with The Life Sciences Report, read more
http://blog.zandcell.com/biotech-stocks-the-new-year-heralds-a-transition-in-stem-cell-development-kapitall-blog-blog/?utm_source=rss&utm_medium=rss&utm_campaign=biotech-stocks-the-new-year-heralds-a-transition-in-stem-cell-development-kapitall-blog-blog
Inga kommentarer:
Skicka en kommentar